Compliance Due Diligence and Health Diagnostic Services
Service 1
Service Definition
Comprehensive compliance assessment for U.S. IPO readiness: identify core risks in corporate structure, financials, data governance, internal controls, and related-party transactions; deliver an IPO feasibility diagnosis report.
Services
Due diligence on corporate fundamentals; VIE/Red-chip structure due diligence; financial compliance review; internal control process diagnosis; cross-border data compliance check; actual controller and board member eligibility assessment; related-party transactions and fund flow review
Service Process
Requirement Confirmation → Data Collection → On-site/Remote Due Diligence → AI Risk Identification → Expert Review → Report Delivery → Remediation Guidance
Target Audience
Companies planning to IPO in the U.S., go public via SPAC, transfer to OTC markets, or restructure as red-chip entities
Deliverables
"IPO Compliance Health Diagnostic Report," "Risk Rectification Checklist," and "IPO Pathway Proposal"
Service Period
7–15 business days
Quality Standards
Covers core SEC/PCAOB/HFCAA checkpoints; risk identification rate ≥ 98%; actionable and verifiable recommendations
SLA Commitment
1-hour response, 48-hour due diligence list submission, on-time diagnostic report delivery
Need professional support?
Our expert team will provide you with tailored compliance solutions.
Book a Consultation